Advertisement
Advertisement

MBIO

MBIO logo

Mustang Bio Inc

0.1681
USD
-0.0089
-5.03%
Dec 18, 15:52 UTC -5
Closed
...

Mustang Bio Inc Profile

About

Mustang Bio, Inc. a subsidiary of Fortress Biotech, Inc., is a clinical?stage biopharmaceutical company. It focused on the development and commercialization of novel cancer immunotherapy products designed to leverage the patient's own immune system to eliminate cancer cells. Mustang Bio, Inc. is based in New York, United States.

Info & Links

CEO

Manuel Litchman

Headquarters

377 PLANTATION STREET
WORCESTER, MA 01605, UNITED STATES

Auditor

KPMG LLP

Share holders

71

Employees

80

Mustang Bio Inc Statistics

Valuation Measures

Market Capitalization2

8.03M

Enterprise Value

4.51M

Enterprise Value/EBITDA(ttm)

-0.20

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-1243.22%

Return on Invested Capital(ttm)

-6785.15%

Return on Assets(ttm)

-172.89%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-22.86M

Net Income Available to Common(ttm)

-23.42M

Diluted EPS(ttm)

-1.56

Share Statistics

Beta (5Y Monthly)

1.80

52-Week Change

-88.41%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

47.78M

Dividend Yield

0.00%

Float4

47.49M

% Held by Insiders

0.60%

% Held by Institutions

9.95%

Balance Sheet

Total Cash(mrq)

3.52M

Total Cash Per Share(mrq)

0.07

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.40%

Quick Ratio(mrq)

0.40%

Book Value Per Share(mrq)

-0.23

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.26

Free Cash Flow(ytd)

-9.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement